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Summary 3,4-Dihydroxy-2-['8F]fluoro-L-phenylalanine (2-["'F]FDOPA) and [6-3H]thymidine ([3H]Thd) were
simultaneously injected into mice transplanted with B16 melanomas or FM3A mammary carcinoma. Melano-
genesis was differentiated from DNA synthesis in the mitotic cell cycle by monitoring grain distribution with
double-tracer microautoradiography. The percentages of pigmented cells were inversely proportional to those
of [3H]Thd-labelled cells, indicating that the greater the number of melanocytes, the smaller was the number of
proliferating cells. The number of grains produced by 2-['8F]FDOPA in the ['H]Thd-unlabelled melanocytes
was significantly higher (P<0.001) than the numbers in the [3H]Thd-labelled melanocytes and in non-
melanocytes. The ['H]Thd-unlabelled non-melanocytes and FM3A cells showed the lowest accumulation of
2-['8F]DOPA, which may have resulted from the basic amino acid demand by malignant neoplasms via amino
acid transport. The [3H]Thd-labelled cells, regardless of whether they were pigmented or not, had slightly more
grains with 2-['8F]FDOPA than the [3H]Thd- unlabelled non-melanocytes (P<0.05), which may have resulted
from the enhanced amino acid requirement for proliferation. Melanogenesis appeared to be activated only in
the non-S phase of the mitotic cycle in melanocytes.
Pigment production, i.e., melanogenesis, involves the special-
ised functioning of melanocytes. Oxidation of tyrosine and
dopa to dopachrome is catalysed by the enzyme tyrosinase
(EC 1.14.18.1), and this is followed by the conversion of
dopachrome into a number of compounds which polymerise
to form melanin, the end product (Seiji et al., 1963; Seiji,
1967; Porta, 1980; Garcia-Carmona et al., 1982; Laskin et al.,
1982; Pawelek & K6rner, 1982). High tyrosinase activity and
high melanin content are unique characteristics of melanoma
(Jacobsohn et al., 1988; Lejczak et al., 1990), and dopa is a
substrate for melanin synthesis in malignant melanoma
(Blois, 1971; Swan, 1974; Stravs-Mombelli & Wyler, 1985;
Porta, 1988).
The production of melanin is a marker of melanoma
differentiation. The relationship between melanogenesis and
melanoma cell proliferation has been subjected to investiga-
tion for the past 20 years (Bennett, 1989; Lejczak et al.,
1990). It is generally accepted that cells labelled with [6-
3H]thymidine ([3H]Thd), a DNA precursor, are in the DNA
synthesis phase (S-phase) of the mitotic cycle and indicate a
proliferating population. With regard to melanogenesis, it
has been shown that 3,4-dihydroxy-2-['8F]fluoro-L-phenyl-
alanine (2-['8F]FDOPA), an analog of L-DOPA, which is a
substrate for melanin synthesis, is incorporated into melanin
(van Lagevelde et al., 1988; Ishiwata et al., 1989; 1991); the
incorporation of this agent serves as an indicator of melano-
genesis. This agent has been shown to be important in
melanoma-specific imaging by positron emission tomography
(PET) (Turner et al., 1985). In this study, we report our
newly developed double-tracer microautoradiography method;
this allows the simultaneous investigation of two distinct
metabolic processes in one experimental model system in
vivo. Using this technique, we determined the relationship
between melanogenesis and the proliferation of melanoma
cells in vivo by monitoring the accumulation of 2-['8F]-
FDOPA, an anlog of a melanin synthesis substrate, and
[3H]Thd, a DNA precursor.
Materials and methods
Quantitative analysis
To determine the relationship between grain numbers and
radioactivity, normal male C3H/He mice were injected intra-
venously with "8F-tracer at different doses from 0.05 to
2.3 mCi (1.85 to 85.1 MBq), and were killed 1 min later.
Liver sections (5 jim) were then processed for the first auto-
radiography (ARG; described below), as a uniform radio-
active sample; they were counterstained with eosin, and the
grain numbers per unit area were counted under a transmit-
ted light brightfield microscope, using a micrometer. Other
5-jm sections of the same samples were attached to thin
polyethylene films, air-dried, and cut into 6-mm-diameter
circles with a punch. The radioactivity in the punched out
section was then measured with a gamma-counter. Cross
calibration between the gamma-counter and a well-type dose
meter was performed for '8F. The radioactivity per unit area
of the section was then calculated and corrected for decay
(Yamada et al., 1990). We found that there was a linear
relationship between grain numbers per 100 jim2 (Y) and the
corresponding '8F radioactivity (fCi/100 jim2, X) (Y =
0.42X + 0.35, n = 40, r = 0.9996, P<0.001). These findings
supported the validity of the grain counting method used in
this study for the quantification of microautoradiography.
Double-tracer experiment and tissue sampling
Clean gelatinised glass slides were dipped in NTB2 nuclear
emulsion (Kodak, USA) at 40°C, dried in clean air, and
stored with silica-gel in a dark box at 4°C until use. C57BL/6
male mice with subcutaneously transplanted B16F1 and
B16FIO tumours, and C3H/He male mice with FM3A
tumours were injected with 1 mCi of 2-['8F]FDOPA and
20 jCi of [3H]Thd intravenously through the tail vein. Both
tracers were mixed immediately before injection, and the
total volume given per mouse was adjusted to 0.2 ml with
saline. The mice were killed 1 h later, and the tumours were
quickly removed and prepared for frozen sectioning, as
reported previously (Yamada et al., 1990). In brief, the trim-
med tumour samples were embedded in medium (O.C.T.
compound; Miles Inc., USA) and frozen with isopentane
cooled with liquid nitrogen. The frozen sample blocks were
sectioned on a cryostat at -25°C.
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First ARG processfor 2-['8F]FDOPA
Under a safety light, the frozen 5-tm sections were directly
mounted on slides coated with NTB2 emulsion cooled to
- 15C. The slides were immediately deep-frozen on a flat
dryice block and placed in exposure boxes cooled with dry-
ice. After 4-h exposure, they were transferred to a fixative of
ethanol with 5% acetic acid at - 70C and 18.5°C, for 1 min
at each temperature. The acid ethanol was washed out with
water for 2 min and the autoradiograms were developed in
Konidol-X (Konica, Japan) for 4 min, fixed in Fuji general
purpose fixer (Fuji, Japan) for 8 min, and washed in gently
running water for 30 min at 18.5°C. The slides were then
dried in clean air below 20°C.
Second ARG processfor [3H]Thd
Three days after the first ARG for the complete decay of '8F
(t,= 109.8 min), the second ARG was processed using ET2F
stripping film (Fuji, Japan). Under the safety light, the ET2F
film was stripped from the plate, floated on a solution of
0.05% potassium bromide in 1% glycerin at 18.5°C, and then
placed on the slide to cover the specimen with the first
autoradiogram. The film-coated slides were dried and stored
in exposure boxes with silica-gel for 3 weeks at 4°C. After
exposure, the ET2F films were developed for 2 min, fixed for
4 min, and washed and dried as described above. A sche-
matic diagram of the double-tracer micro-ARG procedures is
shown in Figure 1. The cross contaminations were 0.8%
from the 3H to the '8F-autoradiogram, and 0% from the '8F
to the 3H-autoradiogram. The specimens were stained with
hematoxylin and eosin. Non-radioactive tumour sections
were included in each group on a separate slide as a chemo-
graphic control. Grain counts were obtained by focusing a
transmitted light brightfield microscope alternately on the
upper and lower emulsion layers, using a micrometer. The
background level, which may have been produced by scat-
tered radiation or by a non-specific emulsion reaction, was
0.90 ± 0.26 grains/I00 l Lm2, it was subtracted from the rele-
vant data. Cells were microscopically classified by the degree
of pigmentation, as graded by Bennett (1983): unpigmented
and very lightly pigmented cells were classified as non-
melanocytes, and lightly, moderately, and well-pigmented
cells were classified as melanocytes.
The project described in this report utilised animals main-
tained in the animal care facility of our institution and was
fully accredited by the Laboratory Animal Care Committee
of Tohoku University.
bpecimen c!4
Results
Figure 2 shows a pair of double-tracer micro-ARG obtained
with 2-['8F]FDOPA and [3H]Thd. The grains obtained with
2-['8F]FDOPA were diffusely distributed throughout the area,
but some of them overlapped on melanin. The cells in the
S-phase of the mitotic cycle were labelled with [3H]Thd.
Table I shows the [3H]Thd and 2-['8F]FDOPA labelling
indices to total tumour cells and the [3H]Thd labelling indices
to melanocytes in the tissues. The labelling indices of
[3H]Thd (25.2 ± 7.8'-29.3 ± 11.1%, not significant) were
almost the same for B16FI, B16FIO, and FM3A. Most of
the cells examined were labelled with 2-['8F]FDOPA, and
these labelling indices (95.1 ± 1.3- 97.2 ± 2.5%, not signifi-
cant) were also the same for the three cell lines. Forty-four
percent of the cells in B16F1 tissue and less than 20% of the
cells in B16F10 were pigmented (P<0.01). A higher melanin
content was observed microscopically in each B16F1 melano-
cyte than in each B16F1O melanocyte, as shown previously
(Ishiwata et al., 1991). The 3H-labelling indices to melano-
cytes (18.5% in B16F1 and 21.0% in B16F1O) were lower
than those to total tumour cells in the tissue (25.2% and
29.3%, respectively).
The relationship between melanisation and proliferation is
shown in Figure 3. The greater the number of melanocytes in
the tissue was, the smaller was the number of proliferating
cells. The percentages of melanocytes (X) were inversely pro-
portional to those of [3H]Thd-labelled proliferating cells
(Y) in B16F1 (Y=-0.34X + 40.3, r= -0.7633, P<0.001,
n = 19). Although B16F1O also showed the same tendency, it
was not clear (data not shown).
Table II shows the results of2-['8F]FDOPA grain counting
per cell. In both B16F1 and B16F1O, the numbers of grains
were highest (P<0.001) in the [3H]Thd-unlabelled melano-
cytes, indicating that the highest concentration of 2-['8F]
FDOPA occurred in non-S phase melanocytes. [3H]Thd-
unlabelled melanocytes in B16F1 showed a greater accumula-
tion of2-['8F]FDOPA than that shown in B16F10 (P<0.05).
It was correlated to the higher melanin content in each
melanocyte of B16F1 than that of B16F10. The [3H]Thd
unlabelled non-melanocytes and FM3A cells showed the
lowest accumulation of 2-['8F]FDOPA. This uptake seems to
be induced mainly by amino acid transport. The [3H]Thd-
labelled cells, regardless of whether they were pigmented or
not, had slightly more 2-['8F]FDOPA grains (P<0.05) than
the [3H]Thd-unlabelled non-melanocytes. FM3A showed the
same tendency, in that the [3H]Thd-labelled cells had slightly
tripping film
1st ARG process 2nd ARG process
for 2-[1'FlFDOPA
Stripping film
Specimen
Nuclear emulsion
Glass slide
Autoradiogram by 3H
Autoradiogram by 1'8F
Figure 1 A schematic diagram of the double-tracer microautoradiographic procedure for 2-['8F]FDOPA and [3H]Thd.
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Figure 3 Relationship between numbers of melanocytes and
[3H]Thd-labelled cells in B16F1. Three to four sections of each of
five tumours were analysed. The numbers of melanocytes, [3H]
Thd-labelled cells, and total cells in four randomly selected
microgrid areas (100 x 100 jim2) in each section were counted and
_ br eiX fl e in th _I averaged for each po-int. lIhe percentage Of melanlocytes in lne
total number of cells (X) was plotted against the percentage of
b [PH]Thd-labelled cells in the same cells (Y). An inverse propor-
Figure 2 A pair of the double-tracer micro-ARG with 2-['8F]
FDOPA and [3H]Thd (B16F1). a, focused on the 2-['8F]FDOPA
microautoradiogram. b focused on the [3H]Thd microautoradio-
gram. Arrows: some [3H]Thd-labelled cells; Brown pigments:
melanin. Bar: 30 m.
Table I [3H]-Thymidine and 2-['8F]FDOPA labelling indices
Cell 3H1-labelled '8F-labelled Melanocytes 3H-index in
line n (%) ((%) %) melanocytes (%)
B16F1 19 25.2±7.8a 96.6±3.Oa 44.3± 17.4b 18.5±4.3
B16F1O 14 29.3 lI1.la 97.2±2.5a 19.5± 10.0 21.0± 12.8
FM3A 6 27.9±1.2a 95.1 ± 1.3a - -
Each value is the mean±s.d. of three to five tumours. For each
tumour, two to four sections were analysed; for each section, four
microgrid areas (100 x 1I00 Lm2 each) were randomly selected and
averaged. Eachmicrogrid areaincluded 107.0± 11.9cells(nosignificant
difference amongcelllines). n: numberofsections;3H-labelled: [3H]Thd-
labelled cells in the tissue; '8F-labelled: 2-['8F]FDOPA-labelled cells in
the tissue; 3H-index in melanocytes: Percentage of [3H]Thd-labelled
melanocytes to totalmelanocytes. aDifferencenotsignificant among the
three cell lines. bP<0.01 compared to BI6F10 (Student's t-test).
more 2-['8F]FDOPA grains than the [3H]Thd-unlabelled cells;
however, the difference was not significant.
Discussion
In cultured melanin-producing cells, melanogenesis has been
reported to be a function of the growth phase of the cells
(Oikawa et al., 1972; Steinberg & Whittaker, 1976; Monte-
fiori & Kline, 1981; Bennett, 1989), as well as of extracellular
pH and ionic strength (Saeki & Oikawa, 1978; Laskin et al.,
tional relationship was found (Y = - 0.34X + 40.3, r = - 0.7633,
P<0.001), indicating that the greater the number of melanocytes,
the smaller was the number of proliferating cells.
Table II Number ofgrains with2-["8F]FDOPA per cell discriminated
by [3H]Thd-labelling
Melanocytes Non-melanocytes
Cell line n 3H-unlabelled 3H-labelled 3H-unlabelled 3H-labelled
B16F1 19 17.5±3.4a 9.2±3.2b 7.0+0.9bc 8.6±2.1c
B16F10 14 14.3±3.2a 9.5 1.9d 6.91.6d,e 9.2±3.Oe
FM3A 6 - 7.4±1.0 7.9±1.6
Each value is the mean±s.d. of three to five tumours. For each
tumour, two to four sections were analysed; for each section, four
microgrid areas (100 x 1I00 lm2 each) were randomly selected and
averaged. Eachmicrogrid areaincludes 107.0± 11.9cells(nosignificant
differences among cell lines). n: number of sections; 3H-unlabelled:
[3H]Thd-unlabelledcells; 3H-labelled: [3H]Thd-labelled cells. ap<0.001
compared to any other cells in each cell line, and P<0.05 between two
cell lines. bP<O.Ol, cP<0.005, dp<O.00l, CP<0.05 in each pair.
There were no significant differences in the cells among the three cell
lines, except for 3H-unlabelled melanocytes (aP<0.05).
1980; Bennett, 1983). However, B16/C3 cells have been
reported to produce no pigment during the growth phase
(Laskin et al., 1982); these cells underwent melanogenesis at a
specific time after plating. In vivo tumours are composed of
functionally and morphologically more heterogeneous popu-
lations of neoplastic cells than cultured cells (Kreider &
Schmoyer, 1975); it has therefore been more difficult to inves-
tigate melanogenesis in vivo.
In this study, the localisation and differentiation of mela-
nogenesis from DNA synthesis were successfully demonstrat-
ed for the first time at the cellular level in vivo, by a newly
developed double-tracer microautoradiography technique.
Non-S phase melanocytes primarily metabolised 2-['8F]
FDOPA; these cells were therefore considered to be
exhibiting active melanogenesis, and the melanogenetic
activity was higher in B16Fl than in B16F1O. Since tyro-
sinase activity is involved in melanogenesis (Seiji et al., 1963;
Seiji, 1967; Porta, 1980; Garcia-Carmona et al., 1982; Laskin
et al., 1982; Pawelek & Korner, 1982; Lejczak et al., 1990),
non-S phase melanocytes were considered to have higher
tyrosinase activity than cells in other states, especially in
B16F1.
On the other hand, non-S phase non-melanocytes in both
B16 tumours and non-S phase FM3A cells showed similar
low accumulations of 2-['8F]FDOPA, which may have result-
ed from the basic amino acid requirements of malignant
neoplasms, exerted via amino acid transport (Ishiwata et al.,
1989). The S-phase non-melanocytes showed a greater
accumulation of 2-['8F]FDOPA than the non-S phase non-
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melanocytes and the non-S phase FM3A cells. The accumu-
lation in the S-phase non-melanocytes may have resulted
from the enhanced amino acid requirement for proliferation.
It has been shown that fluorodopa is taken up by tumour
cells via a leucine-preferring amino acid transport system
(Oxender et al., 1977). In a study of cultured glioma cells, it
was shown that the higher the DNA synthesis activity,
represented by thmidine uptake, the higher was the "C-
leucine uptake (Ito et al., 1991). In vivo, tumours with a high
thymidine uptake tended to have a high "C-methionine
uptake (Ishiwata et al., 1992). The accumulation of 2-
['8F]FDOPA in non-melanocytes and FM3A cells may be
explained primarily by the amino acid requirement in the
tumour cells. The accumulation of 2-['8F]FDOPA in the
S-phase melanocytes was not significantly different from that
in the S-phase non-melanocytes. The mechanisms underlying
this accumulation in the S-phase melanocytes and the S-
phase non-melanocytes may be the same, i.e., enhanced
amino acid transport. Thus the difference between the
amount of 2-['8F]FDOPA accumulated in the non-S phase
melanocytes and the amount accumulated in the S-phase
melanocytes appeared to be actually incorporated into
melanogenesis. This indicates that active melanogenesis was
limited in non-S phase melanocytes.
The potential usefulness of carbon-11 labelled dopa and
tyrosine has been investigated at 1 h and the incorporation of
L-dopa into melanin was assessed in a trichloroacetic acid
non-extractable fraction (van Langevelde et al., 1988). '8F-
Labelled dopa, which was originally developed for the imag-
ing of dopamine containing structures in the brain, has been
used for melanoma-specific imaging, as '8F has a preferably
longer half-life (109.8 min) than "C (20.3 min) for PET study
(Ishiwata et al., 1989). The selectivity and superiority of
2-['8F]FDOPA over the 6-fluoro analog for incorporation
into melanin in a 6-h period has been shown; it is a better
trancer for melanoma imaging than the 6-fluoro analog (Ishi-
wata et al., 1991). However, both '8F- and "C-labelled dopa
and tyrosine were shown to be accumulated not only into
melanomas, but also in non-melanomas, by accelerated
amino acid transport and/or enhanced amino acid demand
during malignant tumour proliferation (Ishiwata et al., 1989;
1991). The differentiation of melanogenesis from cell propor-
tion seems to be an important approach to exploit in mela-
noma-specific imaging by PET. We consider this differentiation
to be possible, since our study showed that melanogenesis
was differentiated from proliferation by autoradiography.
With regard to clinical applications, 2-['8F]FDOPA-PET
imaging of malignant melanoma may allow visualisation of
total melanogenetic activity and amino acid demand via
amino acid transport (van Langevelde et al., 1988). The
discrimination of melanogenesis from the basic amino acid
demand may be easier with time after injection, since it has
been shown that the incorporation of 2-['8F]FDOPA into
melanin increased with time (Ishiwata et al., 1991). Dual
imaging with 2-['8F]FDOPA and "C-labelled thymidine may
also be useful for evaluations pre- and post-treatment in
maturation/differentiation induction therapy for melanoma,
since increase in the active melanogenetic population induced
by the therapy are considered to lead to greater accumuation
of 2-['8F]FDOPA and lower accumulation of "C-labelled
thymidine in melanoma. Functional imaging and the evalua-
tion of melanoma-specific characteristics are expected.
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